Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind multicenter Phase III trial of Qianlietongshuang capsule in benign prostatic hyperplasia (blood stasis pattern)
CTR20132528Phase 3Completed
- Sponsor
- Chengdu Hekang Pharmaceutical
- Start
- May 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Qianlietongshuang Capsule in benign prostatic hyperplasia (BPH), sponsored by Chengdu Hekang Pharmaceutical. Started May 2014; status: completed.
02
Drugs
Qianlietongshuang Capsule
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on CTR20132528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132528.